Shandong Pharmaceutical Glass Co.Ltd Statistics

Total Valuation

Shandong Pharmaceutical Glass Co.Ltd has a market cap or net worth of CNY 18.40 billion. The enterprise value is 15.60 billion.

Market Cap	18.40B
Enterprise Value	15.60B

Important Dates

The next estimated earnings date is Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	Oct 11, 2024

Share Statistics

Shandong Pharmaceutical Glass Co.Ltd has 663.61 million shares outstanding. The number of shares has increased by 1.74% in one year.

Current Share Class	n/a
Shares Outstanding	663.61M
Shares Change (YoY)	+1.74%
Shares Change (QoQ)	+0.82%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	23.05%
Float	534.16M

Valuation Ratios

The trailing PE ratio is 20.84 and the forward PE ratio is 16.40. Shandong Pharmaceutical Glass Co.Ltd's PEG ratio is 0.86.

PE Ratio	20.84
Forward PE	16.40
PS Ratio	3.58
PB Ratio	2.36
P/TBV Ratio	2.44
P/FCF Ratio	30.85
P/OCF Ratio	n/a
PEG Ratio	0.86

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.54, with an EV/FCF ratio of 26.16.

EV / Earnings	17.69
EV / Sales	3.04
EV / EBITDA	11.54
EV / EBIT	15.52
EV / FCF	26.16

Financial Position

The company has a current ratio of 2.86

Current Ratio	2.86
Quick Ratio	2.23
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	16,722.16

Financial Efficiency

Return on equity (ROE) is 11.63% and return on invested capital (ROIC) is 8.28%.

Return on Equity (ROE)	11.63%
Return on Assets (ROA)	6.61%
Return on Capital (ROIC)	8.28%
Revenue Per Employee	793,048
Profits Per Employee	136,258
Employee Count	6,473
Asset Turnover	0.54
Inventory Turnover	3.08

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.45% in the last 52 weeks. The beta is 0.49, so Shandong Pharmaceutical Glass Co.Ltd's price volatility has been lower than the market average.

Beta (5Y)	0.49
52-Week Price Change	+5.45%
50-Day Moving Average	25.70
200-Day Moving Average	26.28
Relative Strength Index (RSI)	73.76
Average Volume (20 Days)	13,118,209

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Shandong Pharmaceutical Glass Co.Ltd had revenue of CNY 5.13 billion and earned 882.00 million in profits. Earnings per share was 1.33.

Revenue	5.13B
Gross Profit	1.56B
Operating Income	1.01B
Pretax Income	1.05B
Net Income	882.00M
EBITDA	1.35B
EBIT	1.01B
Earnings Per Share (EPS)	1.33

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	2.79B
Total Debt	n/a
Net Cash	2.79B
Net Cash Per Share	4.21
Equity (Book Value)	7.79B
Book Value Per Share	11.74
Working Capital	3.86B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.13 billion and capital expenditures -537.38 million, giving a free cash flow of 596.30 million.

Operating Cash Flow	1.13B
Capital Expenditures	-537.38M
Free Cash Flow	596.30M
FCF Per Share	0.90

Full Cash Flow Statement

Margins

Gross margin is 30.30%, with operating and profit margins of 19.58% and 17.18%.

Gross Margin	30.30%
Operating Margin	19.58%
Pretax Margin	20.49%
Profit Margin	17.18%
EBITDA Margin	26.34%
EBIT Margin	19.58%
FCF Margin	11.62%

Dividends & Yields

This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 2.16%.

Dividend Per Share	0.60
Dividend Yield	2.16%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	30.10%
Buyback Yield	-1.74%
Shareholder Yield	0.42%
Earnings Yield	4.80%
FCF Yield	3.24%

Dividend Details

Stock Splits

The last stock split was on June 20, 2019. It was a forward split with a ratio of 1.4.

Last Split Date	Jun 20, 2019
Split Type	Forward
Split Ratio	1.4

Scores

Shandong Pharmaceutical Glass Co.Ltd has an Altman Z-Score of 6.71.

Altman Z-Score	6.71
Piotroski F-Score	n/a